Catalyst Wire Dossier Catalyst Wire Dossier

Diclofenac diethylamine 2.32% gel

diclofenac diethylamine gel · Novartis
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Diclofenac diethylamine 2.32% gel, covering 2010-11-18 to 2011-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain [Phase 3]

See pricing